To explore the effect of menstrual cycle on choroidal vascularity index (CVI).
Methods
Thirty six eyes of 36 healthy women were included in this prospective study. The menstrual cycles were regular and ranged from 28 to 30 days in length. Optical coherence tomography images were obtained in 3 different phases of the menstrual cycle. The choroidal thickness (CT), total choroidal area, luminal area, stromal area, and CVI were quantified.
Results
Mean subfoveal, nasal and temporal CT were significantly changed in mid-luteal phase in comparison to early follicular (p = 0.018, p = 0.006 and p = 0.001, respectively) and ovulatory phases (p = 0.037, p = 0.037, and p = 0.035, respectively). Mean CVI showed a significant change in mid-luteal phase when compared with early follicular (p = 0.001) and ovulatory phases (p = 0.036).
Conclusion
CVI seemed to be affected in mid-luteal phase of menstrual cycle. This should be considered while analyzing choroidal structure in otherwise healthy women.
HirshorenNTzoranIMakrienkoI, et al.Menstrual cycle effects on the neurohumoral and autonomic nervous systems regulating the cardiovascular system. J Clin Endocrinol Metab2002; 87: 1569–1575.
2.
MillsPJZieglerMGNelesenRA, et al.The effects of the menstrual cycle, race, and gender on adrenergic receptors and agonists. Clin Pharmacol Ther1996; 60: 99–104.
3.
KirklandJLMurthyLStancelGM. Progesterone inhibits the estrogen-induced expression of c-fos messenger ribonucleic acid in the uterus. Endocrinology1992; 130: 3223–3230.
4.
SarrelPM. Ovarian hormones and the circulation. Maturitas1990; 12: 287–298.
5.
GrodsteinFMansonJEColditzGA, et al.A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease. Ann Intern Med2000; 133: 933–941.
CentofantiMZarfatiDManniGL, et al.The influence of oestrogen on the pulsatile ocular blood flow. Acta Ophthalmol Scand Suppl2000; 232: 38–39.
8.
van BaalWMKenemansPStehouwerCD, et al.Sequentially combined hormone replacement therapy reduces impedance to flow within the uterine and central retinal arteries in healthy postmenopausal women. Am J Obstet Gynecol1999; 181: 1365–1373.
9.
MunautCLambertVNoelA, et al.Presence of oestrogen receptor type beta in human retina. Br J Ophthalmol2001; 85: 877–882.
10.
DundarSOOzcuraFCetinED, et al.Effects of estrogen replacement therapy on vascular endothelial growth factor expression in choroidal and retinal vasculature. Bratisl Lek Listy2010; 111: 473–476.
11.
IkunoYMarukoIYasunoY, et al.Reproducibility of retinal and choroidal thickness measurements in enhanced depth imaging and high-penetration optical coherence tomography. Invest Ophthalmol Vis Sci2011; 52: 5536–5540.
12.
SonodaSSakamotoTYamashitaT, et al.Choroidal structure in normal eyes and after photodynamic therapy determined by binarization of optical coherence tomographic images. Invest Ophthalmol Vis Sci2014; 55: 3893–3899.
13.
RichardsonPSRNicholsCParsonsMA, et al.Sex steroid hormone receptors in the human retina and choroid: an immunocytochemical study. Invest Ophthalmol Vis Sci1995; 36: S128.
14.
WickhamLAJianpingGTodaI, et al.Identification of androgen, estrogen, and progesterone receptor mRNAs in the eye. Acta Ophthalmol Scand2000; 78: 146–153.
15.
Harris-YitzhakMHarrisABen-RefaelZ, et al.Estrogen-replacement therapy: effects on retrobulbar hemodynamics. Am J Ophthalmol2000; 129: 623–628.
16.
CentofantiMZarfatiDManniGL, et al.The influence of oestrogen on the pulsatile ocular blood flow. Acta Ophthalmol Scand2000; 232: 38–39.
17.
KavroulakiDGugletaKKochkorovA, et al.Influence of gender and menopausal status on peripheral and choroidal circulation. Acta Ophthalmol2010; 88: 850–853.
18.
SmileyDAKhalilRA. Estrogenic compounds, estrogen receptors and vascular cell signaling in the aging blood vessels. Curr Med Chem2009; 16: 1863–1887.
19.
MagnessRRRosenfeldCR. Local and systemic estradiol-17 beta: effects on uterine and systemic vasodilation. Am J Physiol1989; 256: E536–E542.
20.
BottariSPVokaerAKaivezE, et al.Differential regulation of alpha-adrenergic receptor subclasses by gonadal steroids in human myometrium. J Clin Endocrinol Metab1983; 57: 937–941.
21.
LiuXShiH. Regulation of estrogen receptor α expression in the hypothalamus by Sex steroids: implication in the regulation of energy homeostasis. Int J Endocrinol2015; 2015: 949085.
22.
O’DonnellEFlorasJSHarveyPJ. Estrogen status and the renin angiotensin aldosterone system. Am J Physiol Regul Integr Comp Physiol2014; 307: R498–R500.
23.
ChidambaramMDuncanJALaiVS, et al.Variation in the renin angiotensin system throughout the normal menstrual cycle. J Am Soc Nephrol2002; 13: 446–452.
24.
UlaşFDoğanUDuranB, et al.Choroidal thickness changes during the menstrual cycle. Curr Eye Res2013; 38: 1172–1181.
25.
AgrawalRGuptaPTanKA, et al.Choroidal vascularity index as a measure of vascular status of the choroid: measurements in healthy eyes from a population-based study. Sci Rep2016; 6: 21090.
26.
OhJBaikDJAhnJ. Inter-relationship between retinal and choroidal vasculatures using optical coherence tomography angiography in normal eyes. Eur J Ophthalmol2020; 30: 48–57.
27.
Ruiz-MedranoJRuiz-MorenoJMGoudA, et al.Age-related changes in choroidal vascular density of healthy subjects based on image binarization of swept-source optical coherence tomography. Retina2018; 38: 508–515.
28.
TanRAgrawalRTaduruS, et al.Choroidal Vascularity Index in retinitis Pigmentosa: an OCT study. Ophthalmic Surg Lasers Imaging Retin2018; 49: 191–197.
29.
AgrawalRLiLKHNakhateV, et al.Choroidal vascularity index in Vogt-Koyanagi-Harada disease: an EDI-OCT derived tool for monitoring disease progression. Transl Vis Sci Technol2016; 5: 7.
30.
AgrawalRChhablaniJTanKA, et al.Choroidal vascularity index in central serous chorioretinopathy. Retina2016; 36: 1646–1651.
31.
YangJWangEYuanM,et al.Three-dimensional choroidal vascularity index in acute central serous chorioretinopathy using swept-source optical coherence tomography. Graefe’s Arch. Clin. Exp. Ophthalmol2020; 258: 241–247.
32.
IovinoCPellegriniMBernabeiF, et al. Choroidal vascularity Index: an In-depth analysis of this novel optical coherence tomography parameter. J Clin Med2020; 9: 595.
33.
SmallCMManatungaAKMarcusM. Validity of self-reported menstrual cycle length. Ann Epidemiol2007; 17: 163–170.
